Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany.
Mertens J, Stock S, Lüngen M, von Berg A, Krämer U, Filipiak-Pittroff B, Heinrich J, Koletzko S, Grübl A, Wichmann HE, Bauer CP, Reinhardt D, Berdel D, Gerber A.
Mertens J, et al. Among authors: wichmann he.
Pediatr Allergy Immunol. 2012 Sep;23(6):597-604. doi: 10.1111/j.1399-3038.2012.01304.x. Epub 2012 May 25.
Pediatr Allergy Immunol. 2012.
PMID: 22624978
Clinical Trial.